2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 301–400 of 1,000

1. Early postpartum dyslipidemia and its potential predictors during pregnancy in women with a history of gestational diabetes mellitus
   Ling Pei, Huangmeng Xiao, Fenghua Lai, Zeting Li, Zhuyu Li, Shufan Yue, Haitian Chen, Yanbing Li, Xiaopei Cao · 2020 · Lipids in Health and Disease
2. Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis
   Harpreet Singh Bhatia, Gary S. Ma, Adam Taleb, Michael J. Wilkinson, Andrew M. Kahn, Bruno R. Cotter, Calvin Yeang, Anthony Nicholas DeMaria, Mitul P. Patel, Ehtisham Mahmud et al. · 2022 · Atherosclerosis
3. Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: a secondary-data analysis of a randomized double-blind controlled trial
   Fatemeh Ahmadian, Elham Razmpoosh, Hanieh‐Sadat Ejtahed, Maryam Javadi, Parvin Mirmiran, Fereidoun Azizi · 2022 · Diabetology & Metabolic Syndrome
4. TITAN Trial
   Amy Ashley Kirkham, John Robert Mackey, Richard B. Thompson, Mark J. Haykowsky, Gavin Y. Oudit, Margaret L. McNeely, Richard A. Coulden, Michael K. Stickland, Vickie Elaine Baracos, Jason R.B. Dyck et al. · 2023 · JACC Advances
5. Lipoprotein(a)—60 Years Later—What Do We Know?
   Anna Pasławska, Przemysław Tomasik · 2023 · Cells
6. Aerobic Physical Activity and Depression Among Patients With Cancer
   Matthew Kulchycki, H. Halder, N. Askin, R. Rabbani, Fiona Schulte, M. Jeyaraman, Lillian Sung, Deepak Louis, L. Lix, Allan Garland et al. · 2024 · JAMA Network Open
7. Reprint of: Impact of Lipids on Cardiovascular Health
   Brian A. Ference, Ian M Graham, Lale S Tokgözoğlu, Alberico Luigi Catapano · 2018 · Journal of the American College of Cardiology
8. Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review
   Chaitanya Bhatt, Ethan Lin, Laura Legere, Cynthia Anne Jackevicius, Dennis T. Ko, Douglas S. Lee, Kathryn Schade, Sharon Johnston, Todd J. Anderson, Jacob Allen Udell · 2024 · Journal of the American Heart Association
9. How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
   Kongyong Cui, Dong Yin, Cheng‐Gang Zhu, Weihua Song, Hongjian Wang, Lei Jia, Rui Zhang, Haoyu Wang, Zhongxing Cai, Lei Feng et al. · 2022 · Journal of the American Heart Association
10. Self-rollable Polymer Stent Integrated with Wireless Pressure Sensor for Real-time Monitoring of Cardiovascular Pressure
    Nomin‐Erdene Oyunbaatar, Dong-Su Kim, Prasad Gajula, Yun‐Jin Jeong, Dong‐Weon Lee · 2022 · Sensors and Actuators A Physical
11. A Systematic Review on the Risk Modulators of Myocardial Infarction in the “Young”—Implications of Lipoprotein (a)
    Cristian Stătescu, Larisa Anghel, Laura-Cătălina Benchea, Bogdan-Sorin Tudurachi, Andreea Leonte, Alexandra Zăvoi, Ioana Mădălina Zota, Cristina Prisacariu, Rodica Radu, Ionela-Lăcrămioara Șerban et al. · 2023 · International Journal of Molecular Sciences
12. Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis
    Han Zhang, Yin Zhang, Tao Tian, Tianjie Wang, Jue Chen, Jinqing Yuan, Jie Qian, Fenghuan Hu, Kefei Dou, Shubin Qiao et al. · 2023 · Journal of clinical lipidology
13. Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
    Justine Cole, Rafael Zubirán, Anna T Wolska, Ishwarlal Jialal, Alan Thomas Remaley · 2023 · Journal of Clinical Medicine
14. The association between insomnia symptoms and cardiovascular risk factors in patients who complete outpatient cardiac rehabilitation
    Codie R. Rouleau, Kirsti Toivonen, Sandeep Aggarwal, Ross A Arena, Tavis S. Campbell · 2017 · Sleep Medicine
15. Ultrasound-based stroke/cardiovascular risk stratification using Framingham Risk Score and ASCVD Risk Score based on “Integrated Vascular Age” instead of “Chronological Age”: a multi-ethnic study of Asian Indian, Caucasian, and Japanese cohorts
    Ankush D. Jamthikar, Deep Gupta, Elisa Cuadrado‐Godia, Anudeep Puvvula, Narendra Nath Khanna, Luca Saba, Klaudija Višković, Sophie I. Mavrogeni, Monika Turk, John R. Laird et al. · 2020 · Cardiovascular Diagnosis and Therapy
16. Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis
    Harpreet Singh Bhatia, Rishi Raj Rikhi, Tara S. Allen, Calvin Yeang, Weihua Guan, Parveen K. Garg, Michael Y. Tsai, Michael H. Criqui, Michael David Shapiro, Sotirios Tsimikas · 2023 · Atherosclerosis
17. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate
    Ewelina Młynarska, Emilian Budny, Maciej Saar, Ewa Wojtanowska, Justyna Jankowska, Szymon Marciszuk, Marcin Mazur, Jacek Rysz, Beata Franczyk · 2024 · International Journal of Molecular Sciences
18. A Comparative Analysis of Current Lipid Treatment Guidelines
    Anjan Tibrewala, Arif Jivan, William J. Oetgen, Neil J. Stone · 2018 · Journal of the American College of Cardiology
19. Prevention and management of statin adverse effects: A practical approach for pharmacists
    Arden R. Barry, Jessica E. Beach, Glen J. Pearson · 2018 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
20. Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome
    Bradley Sarak, Anamaria Savu, Padma Kaul, Finlay Aleck McAlister, Robert C. Welsh, Andrew Tze-Kay Yan, Shaun G. Goodman · 2021 · Circulation Cardiovascular Quality and Outcomes
21. Development of a Portfolio Diet Score and Its Concurrent and Predictive Validity Assessed by a Food Frequency Questionnaire
    Andrea J. Glenn, Beatrice A. Boucher, Chloe Kavcic, Tauseef Ahmad Khan, Melanie A. Paquette, Cyril W.C. Kendall, Anthony J. Hanley, David J.A. Jenkins, John L. Sievenpiper · 2021 · Nutrients
22. Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease
    Nathaniel Mark Hawkins, Sandra Peterson, Allison M. Ezzat, Rohit Vijh, Sean Virani, Andrew G. Gibb, G.B. John Mancini, Sabrina T. Wong · 2022 · Annals of the American Thoracic Society
23. The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review
    Muhammad Jami Husain, Garrison Spencer, Rachel A. Nugent, Deliana Kostova, Patricia Richter · 2022 · Global Heart
24. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients
    Sean G. Kelly, Karen Krueger, Jennifer L. Grant, Sudhir Penugonda, Matthew J. Feinstein, Babafemi Taiwo, Chad J. Achenbach · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
25. The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale, implications, and implementation
    Nicole E.M. Jaspers, Paul M. Ridker, Jannick A N Dorresteijn, Frank L.J. Visseren · 2018 · Current Opinion in Lipidology
26. Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
    Rosemary Brown, Paul I. Welsh, Jennifer Logue · 2020 · Open Heart
27. Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study
    Kexin, Wang, Yaodong, Ding, Wen, Gao, Rui, Wang, Jiaxin, Yang, Xiaoli, Liu, Hua, Shen, Hailong, Ge · 2021 · Frontiers in Cardiovascular Medicine
28. Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting
    Ziyu Zhang, Maya Rodriguez, Ze Zheng · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
29. Comparison of Cardiovascular Risk Factors and Outcomes Among Practicing Physicians vs the General Population in Ontario, Canada
    Dennis T. Ko, Anna Chu, Peter C. Austin, Sharon Johnston, Brahmajee K. Nallamothu, Idan Roifman, Natasa Tusevljak, Jacob Allen Udell, Erica Frank · 2019 · JAMA Network Open
30. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
    Roberto Pontremoli, Vincenzo Bellizzi, Stefano Bianchi, Roberto Bigazzi, Valeria Cernaro, Lucia Del Vecchio, Luca De Nicola, Giovanna Leoncini, Francesca Mallamaci, Carmine Zoccali et al. · 2020 · Journal of Nephrology
31. Evaluation and Management of Dyslipidemia in Patients Treated with Lorlatinib
    Normand Blais, Jean‐Philippe Adam, John Nguyen, Jean C. Grégoire · 2021 · Current Oncology
32. Maternal cardiovascular disease after twin pregnancies complicated by hypertensive disorders of pregnancy: a population-based cohort study
    Liran Hiersch, Joel Geoffrey Ray, Jon F.R. Barrett, Howard M Berger, Michael Patrick Geary, Sarah Diana McDonald, Christina C. Diong, Sima Gandhi, Jun Guan, Beth Murray‐Davis et al. · 2021 · Canadian Medical Association Journal
33. Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021
    Maria Cristina de Oliveira Izar, Viviane Zorzanelli Rocha, Adriana Bertolami, Raul Dias Santos, Ana Maria Lottenberg, Marcelo Heitor Vieira Assad, José Francisco Kerr Saraiva, Ana Paula Marte Chacra, Tânia Leme da Rocha Martinez, Luciana Bahia et al. · 2021 · Arquivos Brasileiros de Cardiologia
34. Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up?
    Victoria Higgins, Lawrence A. Leiter, Sarah R. Delaney, Daniel R. Beriault · 2021 · Clinical Biochemistry
35. Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis
    Qiyu Liu, Yanqiao Yu, Ruixi Xi, Jingen Li, Runmin Lai, Tongxin Wang, Yixuan Fan, Zihao Zhang, Hao Xu, Jianqing Ju · 2022 · Frontiers in Cardiovascular Medicine
36. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements
    Michael J. Miller, Lale S Tokgözoğlu, Klaus Georg Parhofer, Yehuda Handelsman, Lawrence A. Leiter, Ulf Landmesser, Eliot A. Brinton, Alberico Luigi Catapano · 2022 · Expert Review of Cardiovascular Therapy
37. Effect of Important Food Sources of Fructose-Containing Sugars on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Controlled Feeding Trials
    Xinye Qi, Laura Chiavaroli, Danielle Lee, Sabrina Ayoub‐Charette, Tauseef Ahmad Khan, Fei Au‐Yeung, Amna Ahmed, Annette Cheung, Qi Liu, Sonia Blanco Mejía et al. · 2022 · Nutrients
38. Masters athlete screening study (MASS): incidence of cardiovascular disease and major adverse cardiac events and efficacy of screening over five years
    Barbara N. Morrison, Saul Isserow, Jack A. Taunton, David Oxborough, Nathaniel Moulson, Darren E. R. Warburton, James McKinney · 2023 · European Journal of Preventive Cardiology
39. Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations
    Nicole A. Ciffone, Catherine J. McNeal, Mary P. McGowan, Keith C. Ferdinand · 2023 · American Heart Journal Plus Cardiology Research and Practice
40. Mortality Benefits of Cardiac Rehabilitation in Coronary Artery Disease Are Mediated by Comprehensive Risk Factor Modification: A Retrospective Cohort Study
    Codie R. Rouleau, Daniele Chirico, Stephen B. Wilton, Matthew Kenneth MacDonald, Tianqi Tao, Ross A Arena, Tavis S. Campbell, Sandeep Aggarwal · 2024 · Journal of the American Heart Association
41. Worldwide Dyslipidemia Guidelines
    Marcin A. Bartłomiejczyk, Peter Edward Penson, Maciej Banach · 2019 · Current Cardiovascular Risk Reports
42. Referral to Cardiology Following Postpartum Cardiovascular Risk Screening at the Maternal Health Clinic in Kingston, Ontario
    Rachel A. Gladstone, Jessica Pudwell, Raveen Pal, Graeme Neil Smith · 2019 · Canadian Journal of Cardiology
43. Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
    Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri, Azarisman Shah Mohd Shah · 2019 · Therapeutics and Clinical Risk Management
44. Comparison of non-fasting LDL-C levels calculated by Friedewald formula with those directly measured in Chinese patients with coronary heart disease after a daily breakfast
    Qiu-zhen Lin, Yanqiao Chen, Liling Guo, Qunyan Xiang, Feng Tian, Tie Wen, Ling Liu · 2019 · Clinica Chimica Acta
45. Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review
    Smiksha Munjral, Puneet Ahluwalia, Ankush D. Jamthikar, Anudeep Puvvula, Luca Saba, Gavino Faa, Inder M. Singh, Paramjit S. Chadha, Monika Turk, Amer M. Johri et al. · 2021 · Frontiers in Bioscience-Landmark
46. Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment
    Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted · 2024 · Current Atherosclerosis Reports
47. Relationship between remnant cholesterol and risk of kidney stones in U.S. Adults: a 2007–2016 NHANES analysis
    Lei Yao, Peigang Yang · 2024 · Annals of Medicine
48. Cardiovascular Disease Risk Assessment in the United States and Low- and Middle-Income Countries Using Predicted Heart/Vascular Age
    Duke Appiah, Benjamin D. Capistrant · 2017 · Scientific Reports
49. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection
    Thomas Krahn, Myriam Martel, Ruth Sapir‐Pichhadze, Nadine Kronfli, Julian Falutz, Giovanni Guaraldi, Bertrand Lebouché, Marina B. Klein, Philip Y.N. Wong, Marc Deschênes et al. · 2020 · The Journal of Infectious Diseases
50. The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population
    Michael Khoury, Brian W. McCrindle · 2020 · Canadian Journal of Cardiology
51. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
    Genovefa D. Kolovou, Gerald Francis Watts, Dimitri P. Mikhailidis, Pablo Pérez‐Martínez, Samia Mora, Helen I. Bilianou, George Panotopoulos, Niki Katsiki, Teik Chye Ooi, José López‐Miranda et al. · 2019 · Current Vascular Pharmacology
52. Carotid plaque score is associated with 10-year major adverse cardiovascular events in low–intermediate risk patients referred to a general cardiology community clinic
    Murray F. Matangi, Marie‐France Hétu, David W. J. Armstrong, Jonas P. Shellenberger, Daniel Brouillard, Josh Baker, Ana P Johnson, Nicholas Grubic, Hannah Willms, Amer M. Johri · 2024 · European Heart Journal - Cardiovascular Imaging
53. The Role of Carotid and Femoral Plaque Burden in the Diagnosis of Coronary Artery Disease
    Nicholas Grubic, Kayla N. Colledanchise, Kiera Liblik, Amer M. Johri · 2020 · Current Cardiology Reports
54. Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels
    Nathaniel E. Eraikhuemen, Dovena Lazaridis, Matthew T. Dutton · 2020 · American Journal of Cardiovascular Drugs
55. Lipoprotein (a) and diabetes mellitus: causes and consequences
    Natalie C. Ward, Shayimeera Vickneswaran, Gerald Francis Watts · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
56. Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
    Paul I. Welsh, Claire E. Welsh, Carlos A. Celis-Morales, Rosemary Brown, Lyn D Ferguson, Stuart Robert Gray, Patrick Barry Mark, Jim Lewsey, Donald M. Lyall, Jason M. R. Gill et al. · 2020 · European Heart Journal
57. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease
    Diana N. Vikulova, Mark Trinder, G.B. John Mancini, Simon Neil Pimstone, Liam R. Brunham · 2021 · Canadian Journal of Cardiology
58. Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
    Nermine Laaboub, Céline Dubath, Setareh Ranjbar, Guibet Sibailly, Claire Grosu, Marianna Piras, Didier Délessert, Hélène Richard-Lepouriel, Nicolas Ansermot, Séverine Crettol et al. · 2022 · BMC Psychiatry
59. Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
    Lijin Lin, Ke‐Qiong Deng, Ze Chen, Fang Lei, Juan‐Juan Qin, Xuewei Huang, Tao Sun, Xingyuan Zhang, Yingying Hu, Peng Zhang et al. · 2023 · Atherosclerosis
60. Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?
    Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, Alessandro Picci, Filippo Capilupi, Patrizio Capilupi, Luca Bulfone, Antonio Vacca, Nicole Bertin, Cinzia Vivarelli et al. · 2023 · International Journal of Molecular Sciences
61. Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
    Len Kelly, Cai-Lei Matsumoto, Yoko Schreiber, Janet Gordon, Hannah Willms, Christopher Olivier, Sharen Madden, Josh Hopko, Sheldon W. Tobe · 2019 · CMAJ Open
62. Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting
    Anish Nikhanj, Haran Yogasundaram, Bailey Miskew Nichols, Janice Richman–Eisenstat, Cecile L. Phan, Jeffrey Alexander Bakal, Zaeem Azfer Siddiqi, Gavin Y. Oudit · 2020 · Journal of the American Heart Association
63. Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience
    Sumayah Aljenedil, Latifah Alothman, Alexandre M. Bélanger, Leslie Brown, Zubin Lahijanian, Jean Bergeron, Patrick Couture, Alexis Wilfrid Baass, Isabelle L. Ruel, Diane Brisson et al. · 2020 · Atherosclerosis
64. Which lipids should be analyzed for diagnostic workup and follow-up of patients with hyperlipidemias?
    Langlois, Michel R., Nordestgaard, Børge G. · 2018 · Current Cardiology Reports
65. Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles
    Anne Langsted, Børge Grønne Nordestgaard · 2024 · Clinical Chemistry
66. Lp(a): A Rapidly Evolving Therapeutic Landscape
    Khalil Anchouche, George Thanassoulis · 2024 · Current Atherosclerosis Reports
67. LDL cholesterol: How low to go?
    Chris J. Packard · 2017 · Trends in Cardiovascular Medicine
68. Trends in cardiovascular care and event rates among First Nations and other people with diabetes in Ontario, Canada, 1996–2015
    Anna Chu, Lu Han, Idan Roifman, Douglas S. Lee, Michael Green, Kristen M. Jacklin, Jennifer D. Walker, Roseanne Sutherland, Shahriar Khan, Eliot Frymire et al. · 2019 · Canadian Medical Association Journal
69. Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes
    Deepika Laddu, Cemal Ozemek, Trina Hauer, Codie R. Rouleau, Tavis S. Campbell, Stephen B. Wilton, Sandeep Aggarwal, Leslie D. Austford, Ross A Arena · 2019 · International Journal of Cardiology
70. Postprandial dyslipidemia in insulin resistant states in adolescent populations
    Victoria Higgins, Khosrow Adeli · 2020 · Journal of Biomedical Research
71. Low-volume walking HIIT: Efficient strategy to improve physical capacity and reduce the risk of cardiovascular disease in older women with type 2 diabetes
    Alexis Marcotte‐Chénard, Dominic Tremblay, Marie- Michelle Mony, Martin Brochu, Isabelle J. Dionne, Marie‐France Langlois, Warner Mbuila Mampuya, José A. Morais, Daniel Tessier, Éléonor Riesco · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
72. Circulating level of homocysteine contributes to diabetic retinopathy associated with dysregulated lipid profile and impaired kidney function in patients with type 2 diabetes mellitus
    Xiaosi Chen, Xinyuan Zhang, Yao Nie, Zhizhong Gong, Sobha Sivaprasad, Adrian Tien-chin Fung, Qiyun Wang, Bingjie Qiu, Rui Xie, Yanhong Wang · 2022 · Eye
73. The Inherited Hypercholesterolemias
    Wann Jia Loh, Gerald Francis Watts · 2022 · Endocrinology and Metabolism Clinics of North America
74. Associations of Dyslipidemia with Dietary Intakes, Body Weight Status and Sociodemographic Factors among Adults in the United Arab Emirates
    Habiba I. Ali, Fadima Elmi, Lily Stojanovska, Naser Ibrahim, Leila Cheikh Ismail, Ayesha Salem Al Dhaheri · 2022 · Nutrients
75. Methods of Low-Density Lipoprotein-Cholesterol Measurement: Analytical and Clinical Applications.
    S M Touhidul Islam, Bremansu Osa-Andrews, Patricia M Jones, Alagar Raju Muthukumar, Ibrahim A. Hashim, Jing Cao · 2022 · PubMed Central
76. Effectiveness and Feasibility of Telehealth-Based Dietary Interventions Targeting Cardiovascular Disease Risk Factors: Systematic Review and Meta-Analysis
    Rupal Trivedi, Shaimaa Elshafie, Randall L. Tackett, Henry Nolan Young, Elisabeth Lilian Pia Sattler · 2023 · Journal of Medical Internet Research
77. The ins and outs of lipoprotein(a) assay methods
    Maryam Heydari, Majid Rezayi, Massimiliano Ruscica, Tannaz Jamialahmadi, Thomas Patrick Johnston, Amirhossein Sahebkar · 2024 · Archives of Medical Science - Atherosclerotic Diseases
78. Photodynamic Therapy for Atherosclerosis: Past, Present, and Future
    Yanqing Lin, Ruosen Xie, Changyuan Yu · 2024 · Pharmaceutics
79. Lp(a): Addressing a Target for Cardiovascular Disease Prevention
    Nestor Vasquez, Parag H. Joshi · 2019 · Current Cardiology Reports
80. The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease
    Dat T. Tran, Dan Palfrey, Robert C. Welsh · 2021 · PharmacoEconomics - Open
81. Disorders of Lipoprotein Metabolism
    Amanda J. Hooper, Robert Alexander Hegele, John R. Burnett · 2022 · Springer eBooks
82. Lipoprotein (a): Underrecognized Risk with a Promising Future
    Matteo Manzato, R. Scott Wright, Allan S. Jaffe, Vlad C. Vasile · 2024 · Reviews in Cardiovascular Medicine
83. New Insights into the Association between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: An Intravascular Optical Coherence Tomography Study
    Jun Wang, Lu Jia, Xing Li, Siyu Jin, Xiao‐Mei Li, Fen Liu, Chunfang Shan, Yu Zhang, Yi‐Ning Yang · 2019 · Cardiovascular Therapeutics
84. Simvastatin inhibits the adipogenesis of bone marrow‑derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling
    Yao Guo, Jianzhong Huo, Dou Wu, Haihu Hao, Xinghua Ji, Enzhe Zhao, Boyuan Nie, Qiang Liu · 2020 · International Journal of Molecular Medicine
85. Optimizing screening and management of cardiovascular health in prostate cancer
    Miran Kenk, Jean C. Grégoire, Marc‐André Côté, Kim Alexander Connelly, Margot K. Davis, George K. Dresser, Nina Ghosh, Shaun G. Goodman, Christopher Bryce Johnson, Neil Eric Fleshner · 2020 · Canadian Urological Association Journal
86. Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases
    Ежов Марат Владиславович, Svetlana Anatolievna Shalnova, Elena Borisovna Yarovaya, Vladimir Aleksandrovich Kutsenko, С. Е. Евстифеева, Victoria A. Metelskaya, Oxana M. Drapkina, Sergey Anatol'evich Boytsov · 2021 · Archives of Medical Science
87. Recommended and observed statin use among U.S. adults – National Health and Nutrition Examination Survey, 2011-2018
    Angela M. Thompson‐Paul, Cathleen Gillespie, Hilary K. Wall, Fleetwood V Loustalot, Laurence S. Sperling, Yuling Hong · 2022 · Journal of clinical lipidology
88. Modified dietary fat intake for treatment of gallstone disease in people of any age
    Angela Mary Madden, Nigel Smeeton, Alison Culkin, Daksha P Trivedi · 2024 · Cochrane Database of Systematic Reviews
89. An Evidence-Based Guide to Cholesterol-Lowering Guidelines
    David D. Waters, S. Matthijs Boekholdt · 2016 · Canadian Journal of Cardiology
90. Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events
    Yiming M. Zhu, Subodh Verma, Marinda Fung, Matthew McQueen, Todd J. Anderson, Eva Lonn · 2017 · Canadian Journal of Cardiology
91. Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland
    Céline Dubath, Aurélie Delacrétaz, Anaïs Glatard, Péter Vollenweider, Martin Preisig, Hélène Richard-Lepouriel, Roland Hasler, Franziska Gamma, Alessandra Solida, Jacques Thonney et al. · 2020 · The Journal of Clinical Psychiatry
92. Display of Microbial Glucose Dehydrogenase and Cholesterol Oxidase on the Yeast Cell Surface for the Detection of Blood Biochemical Parameters
    Shiyao Zhao, Dong Sheng Guo, Quanchao Zhu, Weiwang Dou, Wenjun Guan · 2020 · Biosensors
93. Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes
    Daniel Elías-López, Benjamin Nilsson Wadström, Signe Vedel‐Krogh, Camilla Jannie Kobylecki, Børge Grønne Nordestgaard · 2024 · Current Diabetes Reports
94. Gender difference in lipoprotein(a) concentration as a predictor of coronary revascularization in patients with known coronary artery disease
    Federico Bigazzi, Fabrizio Minichilli, Francesco Sbrana, Beatrice Dal Pino, Alberto Corsini, Gerald Francis Watts, Cesare Riccardo Sirtori, Massimiliano Ruscica, Tiziana Sampietro · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
95. Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018
    Erin S. Mackinnon, Ron A. Goeree, Shaun G. Goodman, Raina M. Rogoza, Millicent Packalen, L. Pericleous, Ponda Motsepe-Ditshego, PAUL I. OH · 2021 · CJC Open
96. Common Bean Baked Snack Consumption Reduces Apolipoprotein B-100 Levels: A Randomized Crossover Trial
    Alejandro Escobedo, Edgar Alfonso Rivera-León, Claudia Luévano‐Contreras, Judith Esmeralda Urías‐Silvas, Diego A. Luna‐Vital, Norma Morales-Hernández, Luís Mojica · 2021 · Nutrients
97. Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients
    Francesco Baratta, Francesco Angelico, Maria Del Ben · 2023 · International Journal of Environmental Research and Public Health
98. Insights Into the Current Management of Older Adults With Type 2 Diabetes in the Ontario Primary Care Setting
    Graydon S. Meneilly, Lori Berard, ALICE Y.Y. CHENG, Peter Lin, Lori MacCallum, Ross T. Tsuyuki, Jean‐François Yale, Nahal Nasseri, Jean-François Richard, Lianne Goldin et al. · 2017 · Canadian Journal of Diabetes
99. Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial
    Robert Dufour, G. Kees Hovingh, John R. Guyton, Gisle Langslet, Marie T. Baccara‐Dinet, Chantal Din-Bell, Garen Z. Manvelian, Michel Farnier · 2018 · Journal of clinical lipidology
100. Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis
     Eline Houben, Arielle Mendel, Joost W van der Heijden, Suat Şimşek, Willem A. Bax, Simon Carette, Alexandre E. Voskuyl, Christian Pagnoux, Erik Lars Penne · 2019 · Lara D. Veeken